Regulus Therapeutics Inc.
Pharmaceutical company · San Diego, California, United States
Regulus Therapeutics Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2009. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $300,000 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2021.
Regulus Therapeutics at a glance
What does Regulus Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $300,000 in total (2020).
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $34.6 million sold (2021).
Frequently asked questions about Regulus Therapeutics
Where is Regulus Therapeutics headquartered?
Regulus Therapeutics Inc. is headquartered in San Diego, California, United States.
What does Regulus Therapeutics do?
Regulus Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Regulus Therapeutics founded?
The earliest incorporation on record for Regulus Therapeutics Inc. is in 2009, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.